FEATURES OF THE BEHAVIOR OF MOLECULAR BIOLOGICAL MARKERS IN POLYCYSTIC OVARIAN DISEASE DEPENDING ON CLINICAL MANIFESTATIONS IN WOMEN WITH INFERTILITY

Abstract

Despite the fact that there is an active search for new universal diagnostic, therapeutic and/or prognostic molecular biological markers for polycystic ovary syndrome, the problem of full diagnosis and tactics for choosing targeted therapy has not yet been solved.

However, molecular biology research opens up new ways to understand genetic disorders and makes it possible to apply the information obtained in clinical practice. Thus, the study of molecular genetic disorders will allow the development of new targeted drugs, which will contribute to the further development of individualization of therapy for each patient. Of course, the basis for making decisions on treatment tactics will be molecular diagnostics, which, along with the clinical features of the pathological process, will gain more and more knowledge and experience and will contribute to early diagnosis and monitoring of the disease, as well as improved treatment results.